4//SEC Filing
Crowley John J 4
Accession 0000899243-20-017883
CIK 0001805890other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:46 AM ET
Size
10.3 KB
Accession
0000899243-20-017883
Insider Transaction Report
Form 4
Crowley John J
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-06-25+26,972→ 26,972 totalExercise: $17.00Exp: 2030-06-18→ Common Shares (26,972 underlying) - Award
Stock Option (Right to Buy)
2020-06-25+60,852→ 60,852 totalExercise: $17.00Exp: 2030-06-25→ Common Shares (60,852 underlying) - Award
Stock Option (Right to Buy)
2020-02-06+38,561→ 38,561 totalExercise: $2.99Exp: 2030-01-10→ Non-Voting Common Shares (38,561 underlying)
Footnotes (3)
- [F1]25% of the shares subject to this option shall vest and become exercisable on January 10, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter. Prior to closing of the Issuer's initial public offering, such Non-Voting Common Shares will convert into Voting Common Shares and subsequently into Common Shares on a one-for-one basis.
- [F2]25% of the shares subject to this option shall vest and become exercisable on June 18, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter.
- [F3]25% of the shares subject to this option shall vest and become exercisable on June 25, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001587972
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 6:46 AM ET
- Size
- 10.3 KB